tiprankstipranks
Fortress Biotech (FBIO)
NASDAQ:FBIO

Fortress Biotech (FBIO) Financial Statements

1,158 Followers

Fortress Biotech Financial Overview

Fortress Biotech's market cap is currently ―. The company's EPS TTM is $-24.568; its P/E ratio is -0.09; Fortress Biotech is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 34.75M$ 17.39M$ 12.43M$ 16.40M$ 16.53M
Gross Profit$ 28.32M$ 9.19M$ -6.23M$ -7.28M$ 9.31M
EBIT$ -6.17M$ -41.46M$ -62.76M$ -53.51M$ -50.22M
EBITDA$ -3.79M$ -37.94M$ -59.72M$ -50.37M$ -47.88M
Net Income Common Stockholders$ -7.05M$ -26.78M$ -21.54M$ -26.97M$ -22.51M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 72.31M$ 86.77M$ 152.48M$ 178.27M$ 208.35M
Total Assets$ 150.55M$ 180.45M$ 263.55M$ 294.30M$ 323.56M
Total Debt$ 67.15M$ 67.16M$ 116.54M$ 118.70M$ 125.41M
Net Debt$ -5.16M$ -19.61M$ -35.95M$ -59.57M$ -82.94M
Total Liabilities$ 163.79M$ 196.66M$ 243.75M$ 244.28M$ 222.21M
Stockholders Equity$ 16.67M$ 18.51M$ 37.80M$ 41.72M$ 61.67M
Cash Flow-
Free Cash Flow$ -10.80M$ -38.26M$ -43.26M$ -47.94M$ -44.29M
Operating Cash Flow$ -16.80M$ -33.22M$ -43.26M$ -47.84M$ -43.27M
Investing Cash Flow$ 5.00M$ -2.04M$ -5.00M$ -391.00K$ -893.00K
Financing Cash Flow$ -2.69M$ -30.38M$ 22.19M$ 18.62M$ 3.75M
Currency in USD

Fortress Biotech Earnings and Revenue History

Fortress Biotech Debt to Assets

Fortress Biotech Cash Flow

Fortress Biotech Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis